Sam Samad - May 11, 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sam Samad
Stock symbol
IDXX
Transactions as of
May 11, 2022
Transactions value $
$0
Form type
4
Date filed
5/13/2022, 06:10 PM
Previous filing
Mar 3, 2022
Next filing
Jul 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Deferred Stock Unit Award +344 344 May 11, 2022 Common Stock 344 Direct F1, F3
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +945 945 May 11, 2022 Common Stock 945 $333.90 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event is earlier.
F3 Not applicable.